Any current/future new fundraising through debt or equity?

The company is evaluating options to capitalize the business and intends to provide updates in the coming months (Page 5). No specific timelines or guidance have been given yet regarding fundraising (Page 5). As of December 31, the outstanding external loan was INR 12 crores, and director loans stood at approximately INR 93.7 crores, totaling about INR 105 crores in net debt (Page 7). No new director loans were taken in the current quarter (Page 7). Management is currently not commenting on funding requirements for growth aspirations but indicated plans may be shared in the future (Page 7). Cl

Any current/future capex/capital investment/strategic investment?

Limited expansion capex for the current year, with plans to open no more than 4 new clinics by the end of this financial year. Plans to strategically expand in Tier 2 cities in the next financial year. Selective refurbishment of older clinics is underway. Ongoing replacement and upgrade of dermatological equipment and machines to phase out older technology. Investments being made in new technology and AI applications to enhance customer consultation and engagement. Management expects better clarity on capex plans by the end of the current quarter. Focus on clinic refurbishment, technology refr

Future growth expectations in sales/revenue/volumes?

Kaya Limited plans to expand its services beyond skin to include Body and Hair verticals in both India and the Middle East. Early response to the Body vertical in India is strong, indicating potential growth in that segment. Plans to open at least 4 new clinics by the end of the financial year, focusing on Tier 2 cities for expansion in the coming years. Ongoing initiatives include refurbishment of older clinics and technology upgrades, which aim to improve customer experience and sales. Business growth is supported by marketing automation, digital initiatives, and customer engagement

Future growth expectations in earnings/operating earnings/profits/EPS?

Management refrains from giving specific revenue or margin guidance for the full year or next 3 years, citing uncertainties (Page 5, 8). Expansion plans include opening 4 new clinics by end of FY '23, with more aggressive growth expected in next financial year, especially targeting Tier 2 cities (Pages 5, 7). Refurbishment and technology refreshment of existing clinics ongoing to improve operations (Pages 5, 7). Mature clinics have EBITDA margins around 25-35%, with scope for improvement through top line growth and cost control (Page 9). Middle East operations currently have lower EBITDA margi

Kaya LtdQ3 FY23Leisure Services

Kaya Ltd Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹312.4Market Cap: ₹474 CrSector: Leisure Services

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

Kaya Limited plans to expand its services beyond skin to include Body and Hair verticals in both India and the Middle East.
Early response to the Body vertical in India is strong, indicating potential growth in that segment.
Plans to open at least 4 new clinics by the end of the financial year, focusing on Tier 2 cities for expansion in the coming years.
Ongoing initiatives include refurbishment of older clinics and technology upgrades, which aim to improve customer experience and sales.
Business growth is supported by marketing automation, digital initiatives, and customer engagement tools to increase footfall and conversions.
Nutraceuticals and product sales through D2C and e-commerce channels are also expected to grow, contributing to overall revenue.
Average transaction size (ATS) is increasing, reflecting higher-value services and packages, which can enhance revenue even with stable or slightly lower customer counts.
Management refrains from giving specific long-term revenue or margin guidance but indicates multiple levers for growth.

Margin guidance

Category 3

Management refrains from giving specific revenue or margin guidance for the full year or next 3 years, citing uncertainties (Page 5, 8).
Expansion plans include opening 4 new clinics by end of FY '23, with more aggressive growth expected in next financial year, especially targeting Tier 2 cities (Pages 5, 7).
Refurbishment and technology refreshment of existing clinics ongoing to improve operations (Pages 5, 7).
Mature clinics have EBITDA margins around 25-35%, with scope for improvement through top line growth and cost control (Page 9).
Middle East operations currently have lower EBITDA margins (~25%) due increased investments in staffing, but expected to improve as revenue grows (Page 9).
Initiatives include marketing automation, digital channels, and expansion into Body and Hair services expected to drive higher transaction values and EBITDA (Pages 7, 8).
Overall, earnings growth expected to come from mix of clinic expansion, service diversification, and operational efficiencies, but no precise EPS targets were disclosed.

See what Kaya Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company is evaluating options to capitalize the business and intends to provide updates in the coming months (Page 5).
No specific timelines or guidance have been given yet regarding fundraising (Page 5).
As of December 31, the outstanding external loan was INR 12 crores, and director loans stood at approximately INR 93.7 crores, totaling about INR 105 crores in net debt (Page 7).
No new director loans were taken in the current quarter (Page 7).
Management is currently not commenting on funding requirements for growth aspirations but indicated plans may be shared in the future (Page 7).
Clinic expansion capex is limited this year, with plans for more aggressive growth and capital expenditure likely in the next financial year (Page 7).

Order book

The transcript does not specifically mention the current or expected order book or pending orders for Kaya Limited. However, some related insights include: - Expansion plans include opening 4 new clinics by the end of the current financial year and additional clinics in the next couple of years, with focus on Tier 2 cities. - Capital expenditure this year is limited due to planned opening of only 4 clinics; next year plans include refurbishment and tech upgrades. - No clear data on order book or pending orders was provided during the call. - Fundraising plans and capitalization options are being evaluated, with updates expected over the next few months. If you are seeking order backlog details, they are not disclosed in this earnings call transcript.

See what Kaya Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Limited expansion capex for the current year, with plans to open no more than 4 new clinics by the end of this financial year.
Plans to strategically expand in Tier 2 cities in the next financial year.
Selective refurbishment of older clinics is underway.
Ongoing replacement and upgrade of dermatological equipment and machines to phase out older technology.
Investments being made in new technology and AI applications to enhance customer consultation and engagement.
Management expects better clarity on capex plans by the end of the current quarter.
Focus on clinic refurbishment, technology refresh, and strategic new clinic openings rather than aggressive expansion in the short term.

Track Kaya Ltd — get its next earnings analysis in your feed

How does Kaya Ltd rank vs peers in Leisure Services?

Pro feature

ThisKaya Ltd

Rev 4Mar 3

See where Kaya Ltd sits in Leisure ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Kaya Ltd rank in Leisure Services?

Compare Kaya Ltd against every Leisure Services company (Q3 FY23) on revenue, margins and earnings-call signals.

View Leisure Services leaderboard →

What Kaya Ltd's management said in earlier quarters

Others in Leisure Services this season

Delta Corp (Q2 FY27)
For the quarter ended 30th September 2026, consolidated net sales/revenue from operations was ₹159.34 crores, down from ₹182.76 crores in the same quarter last…
Le Travenues Technology Ltd (Q2 FY27)
Gross Transaction Value (GTV): ₹5,304.47 crores, up 22% YoY . Key investor presentation takeaways from Le Travenues Technology Ltd's Q2 FY27 investor presentati
Ventive Hospitality Ltd (Q2 FY26)
Direct booking channels growing, especially in India (currently 60% of sales) and Maldives, enhancing margins and revenues. Key concall takeaways from Ventive…
Imagicaaworld Entertainment Ltd (Q2 FY26)
41.8 Cr, up 4.6% from Rs. Key investor presentation takeaways from Imagicaaworld Entertainment Ltd's Q2 FY26 investor presentation — and how it ranks against se

Compare:vs Indian Hotels Co Ltd vs Indian Railway Catering & Tourism Corporation Ltd vs ITC Hotels

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →